1 follower
ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner, and Nobel Prize-winner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.
NMD Pharma
4 followers
Immunome
2 followers
Day One Biopharmaceuticals
1 follower
Isotopen Technologien München
1 follower
Apogee Therapeutics
1 follower
PrognomiQ
1 follower
BioLamina
1 follower
Thermo Fisher Scientific
165 followers
Gilead Sciences
128 followers
Regeneron
93 followers
Neuralink
60 followers
Explore companies